Related Experiment Video
Updated: Mar 3, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Postoperative Atrial Fibrillation Impacted by Completeness of Coronary Revascularization and Antiplatelet Regimen
Qin Jiang1,2,3, Minghui Xie4, Yalu Yu3
1Department of Cardiac Surgery, Sichuan Provincial People's Hospital, Affiliated Hospital of University of Electronic Science and Technology, Chengdu, Sichuan, China, samsph.com.
Insights
Incomplete revascularization after off-pump coronary artery bypass grafting increases postoperative atrial fibrillation (POAF) risk, especially with clopidogrel. Complete revascularization is associated with lower POAF rates, regardless of antiplatelet choice.
Area of Science:
- Cardiovascular Surgery
- Cardiac Surgery Outcomes
- Arrhythmia Research
Background:
- Postoperative atrial fibrillation (POAF) is a frequent complication following off-pump coronary artery bypass grafting (OPCABG).
- Both myocardial ischemia and systemic inflammation are key factors in POAF development.
- POAF is linked to poorer patient outcomes and extended hospital stays.
Purpose of the Study:
- To examine the combined effect of revascularization completeness and antiplatelet therapy on POAF incidence.
- To investigate the relationship between coronary revascularization extent and POAF in OPCABG patients.
Main Methods:
- Retrospective analysis of 505 patients undergoing elective first-time OPCABG.
- Patients categorized into incomplete revascularization (IR) and complete revascularization (CR) groups.
- Comparison of POAF incidence, AF burden, inflammatory markers, and hospital stay between groups.
Main Results:
- POAF incidence was significantly higher in the IR group (39.2%) compared to the CR group (25.1%).
- The IR group exhibited increased AF burden, higher IL-6 and D-dimer levels, and longer hospital stays.
- Among patients on clopidogrel, IR was linked to higher POAF rates (42.6% vs. 25.9%), but this association was not observed with ticagrelor.
Conclusions:
- Incomplete revascularization is a significant risk factor for POAF post-OPCABG, particularly in patients treated with clopidogrel.
- Complete revascularization may mitigate POAF risk, irrespective of the dual antiplatelet therapy regimen used.
- The choice of antiplatelet therapy interacts with revascularization completeness in influencing POAF development.
Objectives:
Postoperative atrial fibrillation (POAF) is a common complication after off-pump coronary artery bypass grafting (OPCABG) and contributes to increased morbidity and prolonged hospital stays. Both myocardial ischemia and systemic inflammation play a critical role in its pathogenesis, which is closely related to the intensity of coronary revascularization and antiplatelet treatment, respectively.
Methods:
This study investigated the impact of the interaction between completeness of coronary revascularization and antiplatelet regimen on POAF incidence.
Results:
A total of 505 eligible patients, undergoing elective first-time OPCABG surgery from May 2017 to May 2024, were reviewed and divided into the incomplete revascularization (IR) group (n = 143) and complete revascularization (CR) group (n = 362) according to the extent of coronary revascularization. The incidence of POAF within the first week post-OPCABG was 39.2% in the IR group versus 25.1% in the CR group (hazard ratio [HR]: 1.70, 95% confidence interval [CI]: 1.18-2.46; p = 0.002). AF burden (10.1% [IQR 4.8%, 16.5%] vs. 6.0% [IQR 2.3%, 9.5%], p = 0.003), inflammatory markers (interleukin-6 [IL-6] on Day 1: 104 ± 20 vs. 98 ± 16 pg/mL, p < 0.001), markers of prothrombotic state (D-dimer on Day 5: 2.6 ± 0.7 mg/L FEU vs. 2.3 ± 0.7 mg/L FEU, p < 0.001), and postoperative hospital stay (10.7 ± 1.8 vs. 10.3 ± 1.8 days, p = 0.006) were significantly higher in the IR group compared to the CR group. Among patients receiving clopidogrel, POAF incidence was 42.6% (IR) vs. 25.9% (CR) (p = 0.001). Among patients receiving ticagrelor, POAF incidence was 25.0% (IR) vs. 22.5% (CR).
Conclusion:
IR was associated with a higher rate of POAF after OPCABG in patients receiving clopidogrel-based DAPT, but not in those receiving ticagrelor-based DAPT.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease IV: Preventive Measures

